Status:
RECRUITING
Genetic Analysis of Uncommon Disease Presentations in Non-US Populations
Lead Sponsor:
National Human Genome Research Institute (NHGRI)
Conditions:
Undiagnosed Diseases
Rare Diseases
Eligibility:
All Genders
2-100 years
Brief Summary
Background: Genetics research over the past 20 years has helped researchers find the causes of many diseases. More powerful tools for genetic testing now exist. Researchers want to use these new tool...
Detailed Description
Study Description: We plan to couple novel techniques of genomic interrogation with more traditional methods involved in genetic discovery to investigate a broad range of diseases and conditions in l...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- To be eligible to participate in this study, an individual must meet all of the following criteria:
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Probands aged \>2 years at enrollment or first-degree relatives of probands (age \>2 years).
- Suspicion of genetic etiology of illness due to strong family history, precocious onset, severity or mildness of phenotype, or all factors being present.
- Affected individuals and unaffected family members, determination of clinical criteria for inclusion will be determined by medical record review prior to participation.
- Ability of participant and their parent or guardian to understand and have willingness to sign a written informed consent and/or assent document.
- EXCLUSION CRITERIA:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Anyone unwilling to provide informed consent (for themselves as adults, on behalf of their children as minors, or on behalf of an adult who is unable to provide consent for themselves) or assent.
- Individuals who have undergone diagnostic testing for a genetic condition AND the test results were positive.
- Evidence that symptoms are secondary or caused by an undiagnosed condition that is unlikely to have a genetic cause.
- In the opinion of the investigator, participant has a condition that would preclude participation in the study by interfering with the participant s ability to engage in the required protocol evaluation and testing.
Exclusion
Key Trial Info
Start Date :
January 14 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 21 2034
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06595940
Start Date
January 14 2026
End Date
August 21 2034
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Mauritius
Moka, Mauritius